Form 8-K - Current report:
SEC Accession No. 0001558370-20-007992
Filing Date
2020-07-02
Accepted
2020-07-02 16:16:07
Documents
13
Period of Report
2020-06-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20200629x8k.htm   iXBRL 8-K 37508
2 EX-10.1 imgn-20200629xex10d1.htm EX-10.1 170144
  Complete submission text file 0001558370-20-007992.txt   351909

Data Files

Seq Description Document Type Size
3 EX-101.SCH imgn-20200629.xsd EX-101.SCH 3035
4 EX-101.LAB imgn-20200629_lab.xml EX-101.LAB 16751
5 EX-101.PRE imgn-20200629_pre.xml EX-101.PRE 9898
6 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20200629x8k_htm.xml XML 4646
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

EIN.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 201009507
SIC: 2834 Pharmaceutical Preparations